These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34551779)

  • 1. Pharmacist-led intervention in treatment non-adherence and associated direct costs of management among ambulatory patients with type 2 diabetes in southwestern Nigeria.
    Ipingbemi AE; Erhun WO; Adisa R
    BMC Health Serv Res; 2021 Sep; 21(1):1000. PubMed ID: 34551779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pharmacist-led intervention in medication adherence and inhaler usage on asthma and chronic obstructive pulmonary disease control: a quasi-experimental study.
    Adisa R; Ufuah UF; Ige OM
    BMC Health Serv Res; 2024 Oct; 24(1):1199. PubMed ID: 39379970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist-led medication therapy management of diabetes club patients at a primary healthcare clinic in Cape Town, South Africa: A retrospective and prospective audit.
    Sonday F; Bheekie A; Van Huyssteen M
    S Afr Med J; 2022 May; 112(6):437-445. PubMed ID: 36217874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a pharmacist-led structured group-based intervention in improving medication adherence and glycaemic control among type 2 diabetes mellitus patients: A randomized controlled trial.
    Ting CY; Ahmad Zaidi Adruce S; Lim CJ; Abd Jabar AHA; Ting RS; Ting H; Osman NA; Ngau E; Talin BA; Muhammad M; Loo SC; Lim SE; Hassali MA
    Res Social Adm Pharm; 2021 Feb; 17(2):344-355. PubMed ID: 32327398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
    Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
    J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Impact of a Pharmacist-Led Educational Campaign on Disease Knowledge, Practices and Medication Adherence for Type-2 Diabetic Patients: A Prospective Pre- and Post-Analysis.
    Khan YH; Alzarea AI; Alotaibi NH; Alatawi AD; Khokhar A; Alanazi AS; Butt MH; Alshehri AA; Alshehri S; Alatawi Y; Mallhi TH
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial.
    Lauffenburger JC; Ghazinouri R; Jan S; Makanji S; Ferro CA; Lewey J; Wittbrodt E; Lee J; Haff N; Fontanet CP; Choudhry NK
    PLoS One; 2019; 14(4):e0214754. PubMed ID: 30939143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.
    Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Giri M
    J Clin Pharm Ther; 2011 Oct; 36(5):602-13. PubMed ID: 21143256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication Management Program: Adherence, Disease-related Knowledge, Health-related Quality of Life, and Glycemic Control for Type 2 Diabetes Mellitus.
    Nazir SUR; Hassali MA; Saleem F; Haque N
    Altern Ther Health Med; 2020 Jul; 26(S2):4-10. PubMed ID: 31634877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
    Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
    J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a Precision Medicine Analysis of a Behavioral Counseling Strategy to Improve Adherence to Diabetes Self-management Among Youth: A Post Hoc Analysis of the FLEX Trial.
    Kahkoska AR; Lawson MT; Crandell J; Driscoll KA; Kichler JC; Seid M; Maahs DM; Kosorok MR; Mayer-Davis EJ
    JAMA Netw Open; 2019 May; 2(5):e195137. PubMed ID: 31150087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice.
    Sarayani A; Mashayekhi M; Nosrati M; Jahangard-Rafsanjani Z; Javadi M; Saadat N; Najafi S; Gholami K
    Int J Clin Pharm; 2018 Apr; 40(2):345-353. PubMed ID: 29435911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
    J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-centered Pharmacist Care in the Hemodialysis Unit: a quasi-experimental interrupted time series study.
    Ismail S; Al-Subhi A; Youssif E; Ahmed M; Almalki A; Seger DL; Seger AC; Cook E
    BMC Nephrol; 2019 Nov; 20(1):408. PubMed ID: 31722680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Rotunno T; Khoan J; Hirsch JD
    Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist-led telehealth disease management program for patients with diabetes and depression.
    Cohen LB; Taveira TH; Wu WC; Pirraglia PA
    J Telemed Telecare; 2020 Jun; 26(5):294-302. PubMed ID: 30691328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.